Visualization of oxytocin release that mediates paired pulse facilitation in hypothalamic pathways to brainstem autonomic neurons

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Piñol, Ramón A ^a   Jameson, Heather ^a   Popratiloff, Anastas ^b   Lee, Norman H ^a   Mendelowitz, David ^a  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CHANNELRHODOPSIN 2; GLUTAMATE RECEPTOR; GLUTAMIC ACID; OXYTOCIN; OXYTOCIN RECEPTOR; RHODOPSIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BRAIN STEM; CARDIAC VAGAL NEURON; CELL ACTIVATION; CHO CELL LINE; FEMALE; HEART RATE; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; MALE; NERVE CELL; NERVE CELL PLASTICITY; NEUROMODULATION; NEWBORN; NONHUMAN; OXYTOCIN RELEASE; PHOTOACTIVATION; PROTEIN EXPRESSION; PULSE FACILITATION; PULSE RATE; RAT; RECEPTOR UPREGULATION; VAGUS NERVE DORSAL NUCLEUS; ANIMAL; CRICETULUS; CYTOLOGY; HYPOTHALAMUS; METABOLISM; NERVE TRACT; SPRAGUE DAWLEY RAT;

ANIMALS; BRAIN STEM; CHO CELLS; CRICETULUS; FEMALE; HYPOTHALAMUS; MALE; NEURAL PATHWAYS; NEURONS; OXYTOCIN; RATS, SPRAGUE-DAWLEY; RECEPTORS, OXYTOCIN;

EID: 84915750911     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0112138     Document Type: Article

References (46)

1. da Silva AQ, Fontes MA, Kanagy NL (2011) Chronic infusion of angiotensin receptor antagonists in the hypothalamic paraventricular nucleus prevents hypertension in a rat model of sleep apnea. Brain Res 1368: 231-238.
2. Coleman CG, Wang G, Park L, Anrather J, Delagrammatikas GJ, et al. (2010) Chronic intermittent hypoxia induces NMDA receptor-dependent plasticity and suppresses nitric oxide signaling in the mouse hypothalamic paraventricular nucleus. J Neurosci 30: 12103-12112.
3. Kc P, Balan KV, Tjoe SS, Martin RJ, Lamanna JC, et al. (2010) Increased vasopressin transmission from the paraventricular nucleus to the rostral medulla augments cardiorespiratory outflow in chronic intermittent hypoxia-conditioned rats. J Physiol 588: 725-740.
4. Kc P, Dick TE (2010) Modulation of cardiorespiratory function mediated by the paraventricular nucleus. Respir Physiol Neurobiol 174: 55-64.
5. Knight WD, Little JT, Carreno FR, Toney GM, Mifflin SW, et al. (2011) Chronic intermittent hypoxia increases blood pressure and expression of FosB/DeltaFosB in central autonomic regions. Am J Physiol Regul Integr Comp Physiol 301: R131-139.
6. Wang J, Irnaten M, Venkatesan P, Evans C, Mendelowitz D (2002) Arginine vasopressin enhances GABAergic inhibition of cardiac parasympathetic neurons in the nucleus ambiguus. Neuroscience 111: 699-705.
7. Grippo AJ, Trahanas DM, Zimmerman RR 2nd, Porges SW, Carter CS (2009) Oxytocin protects against negative behavioral and autonomic consequences of long-term social isolation. Psychoneuroendocrinology 34: 1542-1553.
8. Grippo AJ, Pournajafi-Nazarloo H, Sanzenbacher L, Trahanas DM, McNeal N, et al. (2012) Peripheral oxytocin administration buffers autonomic but not behavioral responses to environmental stressors in isolated prairie voles. Stress 15: 149-161.
9. de Oliveira DC, Chagas MH, Garcia LV, Crippa JA, Zuardi AW (2012) Oxytocin interference in the effects induced by inhalation of 7.5% CO(2) in healthy volunteers. Hum Psychopharmacol 27: 378-385.
10. Stornetta RL, Guyenet PG, McCarty RC (1987) Autonomic nervous system control of heart rate during baroreceptor activation in conscious and anesthetized rats. J Auton Nerv Syst 20: 121-127.
11. Rinaman L (1998) Oxytocinergic inputs to the nucleus of the solitary tract and dorsal motor nucleus of the vagus in neonatal rats. J Comp Neurol 399: 101-109.
12. Pinol RA, Bateman R, Mendelowitz D (2012) Optogenetic approaches to characterize the long-range synaptic pathways from the hypothalamus to brain stem autonomic nuclei. J Neurosci Methods 210: 238-246.
13. Zhang X, Fogel R (2002) Glutamate mediates an excitatory influence of the paraventricular hypothalamic nucleus on the dorsal motor nucleus of the vagus. J Neurophysiol 88: 49-63.
14. Kamendi H, Dergacheva O, Wang X, Huang ZG, Bouairi E, et al. (2006) NO differentially regulates neurotransmission to premotor cardiac vagal neurons in the nucleus ambiguus. Hypertension 48: 1137-1142.
15. Bouairi E, Kamendi H, Wang X, Gorini C, Mendelowitz D (2006) Multiple types of GABAA receptors mediate inhibition in brain stem parasympathetic cardiac neurons in the nucleus ambiguus. J Neurophysiol 96: 3266-3272.
16. Zhao Y, Araki S, Wu J, Teramoto T, Chang YF, et al. (2011) An expanded palette of genetically encoded Ca(2)(+) indicators. Science 333: 1888-1891.
17. Dobrunz LE, Stevens CF (1997) Heterogeneity of release probability, facilitation, and depletion at central synapses. Neuron 18: 995-1008.
18. Mendelowitz D (1996) Firing properties of identified parasympathetic cardiac neurons in nucleus ambiguus. Am J Physiol 271: H2609-2614.
19. Pyner S (2009) Neurochemistry of the paraventricular nucleus of the hypothalamus: implications for cardiovascular regulation. J Chem Neuroanat 38: 197-208.
20. Yang Z, Han D, Coote JH (2009) Cardiac sympatho-excitatory action of PVNspinal oxytocin neurones. Auton Neurosci 147: 80-85.
21. Yang Z, Bertram D, Coote JH (2001) The role of glutamate and vasopressin in the excitation of RVL neurones by paraventricular neurones. Brain Res 908: 99-103.
22. Geerling JC, Shin JW, Chimenti PC, Loewy AD (2010) Paraventricular hypothalamic nucleus: axonal projections to the brainstem. J Comp Neurol 518: 1460-1499.
23. Goncharuk VD, Buijs RM, Jhamandas JH, Swaab DF (2011) Vasopressin (VP) and neuropeptide FF (NPFF) systems in the normal and hypertensive human brainstem. J Comp Neurol 519: 93-124.
24. Saper CB, Loewy AD, Swanson LW, Cowan WM (1976) Direct hypothalamoautonomic connections. Brain Res 117: 305-312.
25. Sawchenko PE, Swanson LW (1982) Immunohistochemical identification of neurons in the paraventricular nucleus of the hypothalamus that project to the medulla or to the spinal cord in the rat. J Comp Neurol 205: 260-272.
26. Gamer M, Buchel C (2012) Oxytocin specifically enhances valence-dependent parasympathetic responses. Psychoneuroendocrinology 37: 87-93.
27. Norman GJ, Cacioppo JT, Morris JS, Malarkey WB, Berntson GG, et al. (2011) Oxytocin increases autonomic cardiac control: moderation by loneliness. Biol Psychol 86: 174-180.
28. McCall C, Singer T (2012) The animal and human neuroendocrinology of social cognition, motivation and behavior. Nat Neurosci 15: 681-688.
29. Stoop R (2002) Neuromodulation by ocytocin and vasopressin. Neuron 76: 142-159.
30. Huber D, Veinante P, Stoop R (2005) Vasopressin and oxytocin excite distinct neuronal populations in the central amygdala. Science 308: 245-248.
31. Breton JD, Veinante P, Uhl-Bronner S, Vergnano AM, Freund-Mercier MJ, et al. (2008) Oxytocin-induced antinociception in the spinal cord is mediated by a subpopulation of glutamatergic neurons in lamina I-II which amplify GABAergic inhibition. Mol Pain 4: 19.
32. Fang LY, Quan RD, Kaba H (2008) Oxytocin facilitates the induction of longterm potentiation in the accessory olfactory bulb. Neurosci Lett 438: 133-137.
33. Lin YT, Huang CC, Hsu KS (2012) Oxytocin promotes long-term potentiation by enhancing epidermal growth factor receptor-mediated local translation of protein kinase Mzeta. J Neurosci 32: 15476-15488.
34. Ninan I (2011) Oxytocin suppresses basal glutamatergic transmission but facilitates activity-dependent synaptic potentiation in the medial prefrontal cortex. J Neurochem 119: 324-331.
35. Stoop R (2012) Neuromodulation by oxytocin and vasopressin. Neuron 76: 142-159.
36. Regehr WG, Carey MR, Best AR (2009) Activity-dependent regulation of synapses by retrograde messengers. Neuron 63: 154-170.
37. Mastitskaya S, Marina N, Gourine A, Gilbey MP, Spyer KM, et al. (2012) Cardioprotection evoked by remote ischaemic preconditioning is critically dependent on the activity of vagal pre-ganglionic neurones. Cardiovasc Res.
38. Eckberg DL, Drabinsky M, Braunwald E (1971) Defective cardiac parasympathetic control in patients with heart disease. N Engl J Med 285: 877-883.
39. La Rovere MT, Specchia G, Mortara A, Schwartz PJ (1988) Baroreflex sensitivity, clinical correlates, and cardiovascular mortality among patients with a first myocardial infarction. A prospective study. Circulation 78: 816-824.
40. Rardon DP, Bailey JC (1983) Parasympathetic effects on electrophysiologic properties of cardiac ventricular tissue. J Am Coll Cardiol 2: 1200-1209.
41. Townend JN, Littler WA (1995) Cardiac vagal activity: a target for intervention in heart disease. Lancet 345: 937-938.
42. Vanoli E, De Ferrari GM, Stramba-Badiale M, Hull SS Jr, Foreman RD, et al. (1991) Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. Circ Res 68: 1471-1481.
43. Waxman MB, Wald RW (1977) Termination of ventricular tachycardia by an increase in cardiac vagal drive. Circulation 56: 385-391.
44. Whitescarver SA, Ott CE, Kotchen TA (1990) Parasympathetic impairment of baroreflex control of heart rate in Dahl S rats. Am J Physiol 259: R76-83.
45. Hauptman PJ, Schwartz PJ, Gold MR, Borggrefe M, Van Veldhuisen DJ, et al. (2012) Rationale and study design of the increase of vagal tone in heart failure study: INOVATE-HF. Am Heart J 163: 954-962 e951.
46. De Ferrari GM, Tuinenburg AE, Ruble S, Brugada J, Klein H, et al. (2014) Rationale and study design of the NEuroCardiac TherApy for Heart Failure Study: NECTAR-HF. Eur J Heart Fail 16: 692-699.